Investing.com - Co-Diagnostics (NASDAQ: CODX) reported third quarter EPS of $-0.200, $0.09 better than the analyst estimate of $-0.290. Revenue for the quarter came in at $2.5K versus the consensus estimate of $200K.
Co-Diagnostics's stock price closed at $1.270. It is up 9.480% in the last 3 months and down -61.560% in the last 12 months.
Co-Diagnostics saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Co-Diagnostics's stock price’s past reactions to earnings here.
According to InvestingPro, Co-Diagnostics's Financial Health score is "fair performance".
Check out Co-Diagnostics's recent earnings performance, and Co-Diagnostics's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar